Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalamanchi, Shalini, Flynn, Harry W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206123/
https://www.ncbi.nlm.nih.gov/pubmed/22069354
http://dx.doi.org/10.2147/OPTH.S23698
Descripción
Sumario:A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

Ejemplares similares